TSE:BCT BriaCell Therapeutics (BCT) Stock Price, News & Analysis C$4.73 -0.07 (-1.46%) As of 10:04 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsHeadlinesBuy This Stock About BriaCell Therapeutics Stock (TSE:BCT) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get BriaCell Therapeutics alerts:Sign Up Key Stats Today's RangeC$4.67▼C$4.7850-Day RangeC$3.80▼C$5.5852-Week RangeC$3.68▼C$20.40Volume1,081 shsAverage Volume17,712 shsMarket CapitalizationC$41.15 millionP/E RatioN/ADividend Yield13.70%Price TargetN/AConsensus RatingN/A Company Overview BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX:BCT) is dedicated to developing novel immunotherapies to fight cancer and improve patients' lives. Immunotherapies have become the forefront of the fight against cancer because they use the body's immune system to destroy cancer cells, offer the potential for higher levels of safety and efficacy than chemotherapy, and may also prevent cancer recurrence. Read More Receive BCT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BriaCell Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BCT Stock News HeadlinesBriaCell Therapeutics Corp.: BriaCell Arranges Scalable Manufacturing with FUJIFILM Biotechnologies for Bria-IMTJuly 15, 2026 | finanznachrichten.deBriaCell Arranges Scalable Manufacturing with FUJIFILM Biotechnologies for Bria-IMT™July 15, 2026 | finance.yahoo.com125X bigger gains than Nvidia?Tech investor Jeff Brown says a new supercycle may be forming in a sector most investors are ignoring, and he believes Elon Musk could be the trigger. The last comparable cycle happened over 20 years ago, producing historical gains as high as 170,000 percent for early movers. Brown calls this next phase the SpaceX Supercycle. Watch Jeff Brown's full briefing on the SpaceX Supercycle before it comes down.August 14 at 1:00 AM | Brownstone Research (Ad)BriaCell Engages Consulting and Branding Firms to Support Commercial and Market Access Evaluation of Bria-IMT™July 7, 2026 | finance.yahoo.comBriaCell Therapeutics Corp.: BriaCell Receives FDA Clearance to Initiate Bria-BRES+ Clinical Study in Breast CancerMay 6, 2026 | finanznachrichten.deBriaCell: Advancing Toward Approval with Late-Stage Breast Cancer ImmunotherapyApril 17, 2026 | theglobeandmail.comBriaCell Shareholders Overwhelmingly Back Board and Auditors at Annual MeetingMarch 20, 2026 | theglobeandmail.comBriaCell to Spotlight Phase 3 Bria-IMT Data and Next-Gen Bria-OTS+ Platform at 2026 AACRMarch 20, 2026 | theglobeandmail.comSee More Headlines BCT Stock Analysis - Frequently Asked Questions How have BCT shares performed this year? BriaCell Therapeutics' stock was trading at C$9.80 at the beginning of 2026. Since then, BCT stock has decreased by 51.7% and is now trading at C$4.73. When did BriaCell Therapeutics' stock split? BriaCell Therapeutics's stock reverse split before market open on Sunday, August 24th 2025.The 1-10 reverse split was announced on Sunday, August 24th 2025. The number of shares owned by shareholders was adjusted after the closing bell on Sunday, August 24th 2025. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. How do I buy shares of BriaCell Therapeutics? Shares of BCT stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. Industry, Sector and Symbol Stock ExchangeTSE SectorHealthcare Industry Biotechnology Sub-IndustryBiotechnology Current SymbolTSE:BCT CIKN/A Webwww.briacell.com Phone604-921-1810FaxN/AEmployees16Year FoundedN/AProfitability EPS (Trailing Twelve Months)C($0.84) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-C$2.37 million Net MarginsN/A Pretax MarginN/A Return on Equity-147.92% Return on Assets-122.71% Debt Debt-to-Equity RatioN/A Current Ratio7.07 Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueC$3.23 per share Price / Book1.47Miscellaneous Outstanding Shares8,700,000Free FloatN/AMarket CapC$41.15 million OptionableNot Optionable Beta1.96 Don't Wait for the OpenAI IPOThe AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.Get This Free Report This page (TSE:BCT) was last updated on 8/14/2026 by MarketBeat.com Staff. From Our PartnersHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredTrump’s New Currency ResetTrump is launching a new $250 bill - but that may be a distraction. Behind the scenes, Executive Order 14241 i...Porter & Company | SponsoredCentral banks bought 710 tonnes - this fund pays monthlyGold is hitting new highs, fueled by tariffs and record central bank demand - 710 tonnes per quarter. JPMorgan...Investors Alley | SponsoredYour 10X AI demo is starting…Keith Kaplan, the AI expert behind tools used by more than 100000 investors, built his models with an investme...TradeSmith | SponsoredWall Street is staring at the wrong AI tradeAnthropic just signed a 9.1 billion dollar, 20 year data center agreement covering 191 megawatts of capacity, ...The Oxford Club | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredWho Really Gets Rich from IPOs?Peter Thiel turned a $500,000 stake in Meta into nearly $1 billion by investing eight years before its IPO. Tr...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BriaCell Therapeutics Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share BriaCell Therapeutics With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
